HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

9-oxo-9,10-dihydroacridine-4-carboxylic acid 3,4-dimethoxyphenethyl amide

structure in first source

Also Known As:

MBLI 87; MBLI-87; MBLI87

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Acridones: 26
    - 9-oxo-9,10-dihydroacridine-4-carboxylic acid 3,4-dimethoxyphenethyl amide: 1
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Acridines: 325
      - Acridones: 26
        9-oxo-9,10-dihydroacridine-4-carboxylic acid 3,4-dimethoxyphenethyl amide: 1

Experts

1.	Arnaud, O: 1 article (03/2011)
2.	Bates, S E: 1 article (03/2011)
3.	Boumendjel, A: 1 article (03/2011)
4.	Di Pietro, A: 1 article (03/2011)
5.	Dumontet, C: 1 article (03/2011)
6.	Falson, P: 1 article (03/2011)
7.	Guitton, J: 1 article (03/2011)
8.	Gèze, A: 1 article (03/2011)
9.	Honorat, M: 1 article (03/2011)
10.	Matera, E L: 1 article (03/2011)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 03/01/2011 - "The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan."

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Irinotecan (Camptosar)
3.	acridone